BioCentury
ARTICLE | Financial News

Strekin raises CHF10M in seed round

June 2, 2017 7:17 PM UTC

On May 31, Strekin AG (Basel, Switzerland) raised CHF10 million ($10.3 million) in its third seed round from undisclosed private investors. The company is developing STR001, a PPAR gamma agonist, to p...